Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients
- 1 January 1995
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 75 (2) , 132-136
- https://doi.org/10.1016/s0002-9149(00)80061-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Treatment of mild hyperhomocysteinemia in vascular disease patients.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.Journal of Clinical Investigation, 1993
- Hyperhomocyst(e)inemia as a Risk Factor for Occlusive Vascular DiseaseAnnual Review of Nutrition, 1992
- No sensory neuropathy during pyridoxine treatment in homocystinuria.Archives of Disease in Childhood, 1991
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.Stroke, 1990
- Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease Effects of pyridoxine and folic acid treatmentAtherosclerosis, 1990
- Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis.Journal of Clinical Investigation, 1976